by Protea Foundation | Mar 14, 2024 | Uncategorized
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms and functional impairment...
by Protea Foundation | Mar 14, 2024 | News
Devastatingly pervasive: 1 in 3 women globally experience violence Younger women among those most at risk: WHO Violence against women remains devastatingly pervasive and starts alarmingly young, shows new data from WHO and partners. Across their lifetime, 1 in...
by Protea Foundation | Mar 13, 2024 | News
Psychedelic Drug Legislative Reform and Legalization in the US Psychedelic drugs are becoming accessible in the US through a patchwork of state legislative reforms. This shift necessitates consensus on treatment models, education and guidance for health care...
